Immediate Impact
7 from Science/Nature 53 standout
Citing Papers
Selpercatinib in Patients With RET Fusion–Positive Non–Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial
2022 Standout
Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial
2022 Standout
Works of K. Salassidis being referenced
Translocation t(10;14)(q11.2:q22.1) fusing the kinetin to the RET gene creates a novel rearranged form (PTC8) of the RET proto-oncogene in radiation-induced childhood papillary thyroid carcinoma.
2000
Distinct frequency ofret rearrangements in papillary thyroid carcinomas of children and adults from Belarus
1999
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| K. Salassidis | 266 | 73 | 219 | 127 | 12 | 468 | |
| Andres I. Roig | 259 | 23 | 118 | 25 | 13 | 496 | |
| J.R. Williams | 269 | 27 | 76 | 15 | 16 | 480 | |
| Masataka Taga | 256 | 9 | 99 | 87 | 16 | 487 | |
| Tanya K. Day | 204 | 20 | 162 | 26 | 15 | 561 | |
| Ranga Robinson | 150 | 16 | 147 | 44 | 10 | 522 | |
| Manuel Luedeke | 217 | 12 | 201 | 70 | 17 | 545 | |
| Mirtha S. Lopez | 302 | 32 | 249 | 7 | 19 | 553 | |
| S. Cowan | 124 | 5 | 55 | 173 | 22 | 480 | |
| Riitta Mustonen | 201 | 48 | 193 | 5 | 13 | 420 | |
| Yeung Ho | 247 | 14 | 170 | 41 | 12 | 507 |
All Works
Loading papers...